Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Bone Marrow Transplantation|May 26, 2010
Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHDA Rager, N Frey, S C Goldstein, et al.Bone Marrow Transplantation|March 15, 2005
Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantationA W Loren, S M Luger, E A Stadtmauer, et al.Bone Marrow Transplantation|May 22, 2024
Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trialsC Ganzel, Y Wang, K Roopcharan, et al.Oncogene|March 16, 2010
Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprogramingF Zhao, A Mancuso, T V Bui, et al.Bone Marrow Transplantation|February 7, 2012
High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCTR Tizon, N Frey, D F Heitjan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapyH C Moore, R Mick, L J Solin, et al.Bone Marrow Transplantation|June 14, 2006
Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantationJ Svoboda, C Andreadis, R Elstrom, et al.Blood|August 15, 2000
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remissionM S Tallman, P A Rowlings, G Milone, et al.Medical Oncology (Northwood, London, England)|January 5, 2000
Stem cell transplantation for metastatic breast cancer: analysis of tumor contaminationE A Stadtmauer, D E Tsai, C J Sickles, et al.Bone Marrow Transplantation|October 6, 2005
Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphomaC Andreadis, S J Schuster, E A Chong, et al.Pageof 4